Our Mission
Together, we will transform public health and infectious disease surveillance through the innovative implementation of NGS and bioinformatics technologies.
Who we are
We are public health scientists committed to improving infectious disease surveillance, food safety, molecular diagnostics, and environmental monitoring.
We bring expertise from previous academia, government, and industry careers working on diverse projects in infectious disease, cancer, biofuels, and strain engineering.
Our experience provides us with a “lean forward” perspective.
We continually strive to push the innovative implementation of technology as efficiently as possible since time is our most valuable resource.
What we believe
NGS technologies used to be the domain of large academic or government research groups.
Advances in sequencing technology and cloud computing have produced the “democratization” of NGS and bioinformatics. This democratization allows any clinical, environmental, or food safety organization, regardless of size and resources, to take advantage of these technologies to advance their core business.
Results are quicker, more affordable, and have higher resolution and accuracy than ever before.
The team
Dr. Joel Sevinsky
CEO/Founder
Ph.D. in Molecular, Cellular, and Developmental Biology from CU Boulder
BA in Microbiology from UC Santa Barbara
Dr. Sevinsky has leveraged over two decades of experience in systems biology and has taken aim at transforming public health and infectious disease surveillance through innovative implementation of NGS and bioinformatics technologies. During a three-year tenure at the Colorado Department of Public Health and Environment, he led several initiatives to build NGS testing and bioinformatics capacity at the state, regional and national levels.
In 2019 Dr. Sevinsky’s ambitions to impact public health exceeded his role as a government scientist, resulting in the formation of Theiagen Genomics. Dr. Sevinsky and his team now work with over four dozen public health laboratories nationally and more than a dozen internationally in Africa and Asia.
Prior to his time in public health, Dr. Sevinsky held several positions in non-profit and industry, working in applied technologies for diverse applications such as biomarker identification and biofuel/biochemical production.
Kevin G. Libuit
Chief Technology Officer
MS and BA in Biology from James Madison University
Mr. Libuit is a public health scientist who has dedicated his career to addressing the challenges of integrating DNA sequencing and bioinformatics technologies that strengthen public health decision making.
Through his advocacy for collaborative and open-source bioinformatics development, Mr. Libuit has become a key figure in the public health bioinformatics community who co-founded the State Public Health Bioinformatics (StaPH-B) consortium and currently serves as Vice-Chair of the Public Health Alliance for Genomic Epidemiology’s (PHA4GE) Bioinformatics Working Group.
Mr. Libuit served as the Bioinformatics Lead Scientist for the Commonwealth of Virginia prior to joining Theiagen. In this role, he was responsible for the development and implementation of bioinformatics solutions for public health laboratories across the Mid-Atlantic Region, USA.
As the Chief Technology Officer of Theiagen Genomics, his role is to advance bioinformatics integration for our public health partners. This work has led to the adoption of Theiagen’s open-source solutions by over 40 US state and local public health laboratories and dozens of academic and government institutions across both South-East Asia and Western Africa.
Mr. Libuit’s success in these initiatives stems from his ability to communicate directly with public health scientists facing critical challenges and allowing these conversations and relationships to guide Theiagen’s software and training development priorities.